A pilot study of sunitinib malate in patients with metastatic uveal melanoma.
about
Adjuvant Therapy of Uveal Melanoma: Current StatusPathways and therapeutic targets in melanomaThe genetics of uveal melanoma: current insightsUveal melanoma: From diagnosis to treatment and the science in between.Management of uveal melanoma: a consensus-based provincial clinical practice guidelineA molecular revolution in uveal melanoma: implications for patient care and targeted therapyIntra-arterial infusion and chemo-embolization for melanoma liver metastases.The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal MelanomaBiology of advanced uveal melanoma and next steps for clinical therapeutics.Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study.Systemic treatment of metastatic uveal melanoma: review of literature and future perspectivesHypothyroidism after a cancer diagnosis: etiology, diagnosis, complications, and managementThe biology of uveal melanomaThe potential role of sunitinib targeting melanomas.Latest developments in the biology and management of uveal melanoma.Metastatic melanoma to the liver: a contemporary and comprehensive review of surgical, systemic, and regional therapeutic options.Benefit, Risk, and Outcomes in Drug Development: A Systematic Review of Sunitinib.Evolving systemic targeted therapy strategies in uveal melanoma and implications for ophthalmic management: a review.Update on Metastatic Uveal Melanoma: Progress and Challenges.The pharmacogenomics of drug resistance to protein kinase inhibitors.Emerging growth factor receptor antagonists for the treatment of advanced melanoma.Histologic and immunohistochemical predictors of clinical behavior for feline diffuse iris melanoma.CD117/c-kit in Cancer Stem Cell-Mediated Progression and Therapeutic Resistance.
P2860
Q26865325-7D338F9E-3F5F-4A8D-86EB-5CBB4F4CDE64Q26865736-09228A21-7883-428B-AA6D-232F9DFB665AQ28073150-FC3116E5-DEAE-4135-B718-82E8181E6B74Q30251762-8CF1F745-4D39-41BC-8253-83452CA83059Q30388575-27A4B0C4-80D0-4858-872A-9CB47408F38BQ33717375-A5E2CF63-7937-49FF-B308-4E9C47684D4FQ34402644-B4F71E73-3BCE-4426-864F-F3C4FD583849Q34671160-52E74464-5FF9-42C6-8F91-5105DE26D448Q35079709-5B7D2E62-B43D-4ACD-AF45-5EBB4DA268FFQ37061324-9F657FA4-F7FA-4DE3-A57C-D554CA249316Q37482566-B39F4F7D-9DD3-495A-9751-CC7C7D88D0EFQ37519042-0F2CE048-FFF4-45B0-8A32-BAAED51CF2BDQ37742632-D85E1BEA-9958-41EA-A661-BE7C01463DD4Q38139560-5A4BC9AE-B616-4187-8CA3-29AFDD27575EQ38152310-FDA9CE5E-CAE8-412D-A300-2B1BF220EC58Q38168469-D1795D75-17C5-4A5E-8572-EEDE3E74C7DFQ38627885-6BDE04B4-7965-49A4-B8BB-4F4FC8ED06FBQ38646057-EC22312F-B082-40A2-92F9-B0A39CEB1242Q38783505-D5B88707-89DD-4444-A682-B1BFF5970703Q38952751-B1F78A1C-1FE5-4E82-A879-5BA5E7F58C24Q39340696-01BA0A68-7B69-4286-9A13-4F39C2F2BD85Q45930485-F5FE58C6-F88B-4B4F-BD92-65625841F6B4Q53703721-7AFEDC73-8BD3-477A-A3E6-98259568DA10
P2860
A pilot study of sunitinib malate in patients with metastatic uveal melanoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
A pilot study of sunitinib malate in patients with metastatic uveal melanoma.
@en
A pilot study of sunitinib malate in patients with metastatic uveal melanoma.
@nl
type
label
A pilot study of sunitinib malate in patients with metastatic uveal melanoma.
@en
A pilot study of sunitinib malate in patients with metastatic uveal melanoma.
@nl
prefLabel
A pilot study of sunitinib malate in patients with metastatic uveal melanoma.
@en
A pilot study of sunitinib malate in patients with metastatic uveal melanoma.
@nl
P2093
P1433
P1476
A pilot study of sunitinib malate in patients with metastatic uveal melanoma
@en
P2093
Kathryn Chan
Lukman Tijani
MaryAnn Laudadio
Michael J Mastrangelo
Takami Sato
P304
P356
10.1097/CMR.0B013E328358B373
P407
P50
P577
2012-12-01T00:00:00Z